Federal judge blocks Massachusetts ban of new painkiller Zohydro
Drug maker Zogenix Inc., won another battle in its war to get its controversial painkiller Zohydro on the market. This week, a Massachusetts federal judge blocked plans by Massachusetts Gov. Deval Patrick to ban prescriptions and sales of the newly
Boys with autism more likely to have been exposed to SSRIs in womb
Boys born to women who took a type of antidepressant during pregnancy were three times more likely to be diagnosed with autism than boys who were not exposed to the drugs in utero, a new study has found. The greatest
Doctor raises red flags regarding heart risks with testosterone therapy
Testosterone replacement therapy may sound attractive with ads promising to build muscle mass and boost libido, but Low T therapy may not be all that it’s cracked up to be, warns Dr. Joe Littlejohn, a urologist at Orlando Health. It
Bayer files motion to dismiss some of its Mirena IUD lawsuits
Bayer Healthcare Pharmaceuticals is hoping to ditch some of the 450 lawsuits it faces over inadequate warnings for possible complications with its Mirena intrauterine device on the grounds that the cases have exceeded the statute of limitations. The Mirena IUD is
European drug regulators investigating heart attack, stroke, death risks with testosterone therapies
The European Medicines Agency (EMA) is reviewing the safety of testosterone therapy after studies showed the treatment increases the risk of strokes, heart attacks and death. The announcement comes three months after the U.S. Food and Drug Administration (FDA) launched a
Anti-seizure drug Stavzor linked to life threatening liver failure
The anti-seizure and mood-stabilizing drug Stavzor and its derivatives has been linked to serious and sometimes fatal liver failure, and the risk is even greater in children younger than age 2 and patients with mitochondrial disease. The Food and Drug
Merck offers $100 million to settle NuvaRing lawsuits
Plaintiff’s lawyers are meeting in Las Vegas this week to determine whether enough claimants opted in on a $100 million settlement offered by Merck & Co. for its contraceptive NuvaRing, which has been linked to life threatening blood clots.
FDA delays decision on diabetes inhaler to review possible cancer risks
The Food and Drug Administration (FDA) has delayed its decision about whether to approve Mannkind Corp.’s Afrezza, an inhaled insulin treatment for diabetes, due to concerns about an increased risk of lung cancer.